Literature DB >> 4000140

[Experiences with nifedipine in the treatment of acute hypertension in childhood].

H Stopfkuchen, D Schranz, R Ziegler, B K Jüngst.   

Abstract

The efficacy of Nifedipine (N) as an antihypertensive drug was assessed in 4 children aged 6-12 years with acute severe hypertension. In one child with a hypertensive encephalopathy N 10 mg administered sublingually in addition to other antihypertensive drugs caused a prompt fall in blood pressure followed by a rapid clinical improvement. In the other 3 children N 10 mg reduced systolic and diastolic blood pressure by 13.7% and 16.4% respectively. This antihypertensive action lasted for about 3-4 hours and was associated with an increase in heart rate by 11.5%. The antihypertensive effects of N are positively related to pretreatment blood pressure. These results provide support that N is a safe and effective drug for controlling blood pressure also in hypertensive emergencies of children.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4000140

Source DB:  PubMed          Journal:  Monatsschr Kinderheilkd        ISSN: 0026-9298            Impact factor:   0.323


  4 in total

1.  Sublingual nifedipine in acute severe hypertension.

Authors:  J H Evans; N J Shaw; J T Brocklebank
Journal:  Arch Dis Child       Date:  1988-08       Impact factor: 3.791

2.  Dosage of nifedipine in hypertensive crises of infants and children.

Authors:  J Lopez-Herce; P Dorao; P de la Oliva; M A Delgado; M C Martinez; F Ruza
Journal:  Eur J Pediatr       Date:  1989-11       Impact factor: 3.183

3.  The safety and use of short-acting nifedipine in hospitalized hypertensive children.

Authors:  Verna Yiu; Elaine Orrbine; Rhonda J Rosychuk; Peter MacLaine; Paul Goodyer; Colette Girardin; Manjula Gowrishankar; Malcolm Ogborn; Julian Midgley; Guido Filler; Frances Harley
Journal:  Pediatr Nephrol       Date:  2004-03-31       Impact factor: 3.714

4.  Treatment of hypertensive crisis in children with nifedipine.

Authors:  J Lopez-Herce; L Albajara; P Cagigas; S Garcia; F Ruza
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.